Trinity Resources, Inc. engages in the exploration and development of natural resource interests. The company is headquartered in Henderson, Nevada. The company went IPO on 2001-07-11. The firm is engaged in research and development targeting treatments of brain diseases. The company is also focused on chemical development of its new drugs dedicated to the symptomatic treatment of Alzheimer’s Disease but can be applied to other neurological diseases due to its platform technology.
Alzex Neuropharma Inc 주요 수익원은 Engineering, Procurement and Construction Services이며, 최신 수익 발표에서 수익은 43,902,000입니다. 지역별로는 Hungary이 Alzex Neuropharma Inc의 주요 시장이며, 수익은 41,995,000입니다.
Alzex Neuropharma Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Alzex Neuropharma Inc의 순손실은 $0입니다.